Furthermore, additional immunocytochemistry tests, such as BAP1 loss and p16 deletion may help distinguishing between benign pleural effusion and MPE, particularly benign mesothelial hyperplasia from malignant pleural mesothelioma [52–54]. The gene discussed is BAP1; the disease is malignant pleural mesothelioma.